Technical Analysis for NBIO - Nascent Biotech Inc

Grade Last Price % Change Price Change
grade F 0.085 -5.56% -0.0050
NBIO closed down 5.56 percent on Friday, August 7, 2020, on 2.35 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical NBIO trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction -5.56%
Inside Day Range Contraction -5.56%
Wide Bands Range Expansion -5.56%
Oversold Stochastic Weakness -5.56%
20 DMA Resistance Bearish -5.56%
50 DMA Resistance Bearish -5.56%
MACD Bearish Signal Line Cross Bearish -5.56%
Older signals for NBIO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Nascent Biotech Inc. is a clinical-stage biopharmaceutical company that develops monoclonal antibodies for the treatment of various forms of cancer. The Company is engaged in the research and development of the antibodies for control of brain and pancreatic cancer in humans. The Company focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The Company owns the license rights to a drug candidate, pritumumab, which it is developing. The Company is primarily focused on developing pritumumab for the treatment of patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma. Pritumumab is a monoclonal antibody. The Company has not generated revenues.
Medicine Cancer Clinical Medicine Biopharmaceutical Drugs Antibodies Treatment Of Cancer Monoclonal Antibodies Glioblastoma Targeted Therapy Anogen Treatment Of Various Forms Of Cancer

Is NBIO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.35
52 Week Low 0.052
Average Volume 261,142
200-Day Moving Average 0.1356
50-Day Moving Average 0.1050
20-Day Moving Average 0.0990
10-Day Moving Average 0.1018
Average True Range 0.0201
ADX 26.32
+DI 22.8929
-DI 14.0714
Chandelier Exit (Long, 3 ATRs ) 0.0937
Chandelier Exit (Short, 3 ATRs ) 0.1409
Upper Bollinger Band 0.1198
Lower Bollinger Band 0.0782
Percent B (%b) 0.16
BandWidth 42.0202
MACD Line -0.0030
MACD Signal Line -0.0014
MACD Histogram -0.0016
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.1048
Resistance 3 (R3) 0.1055 0.0997 0.1015
Resistance 2 (R2) 0.0997 0.0946 0.0993 0.1004
Resistance 1 (R1) 0.0923 0.0915 0.0894 0.0916 0.0993
Pivot Point 0.0865 0.0865 0.0850 0.0861 0.0865
Support 1 (S1) 0.0791 0.0814 0.0762 0.0784 0.0707
Support 2 (S2) 0.0733 0.0783 0.0729 0.0696
Support 3 (S3) 0.0659 0.0733 0.0685
Support 4 (S4) 0.0652